» Articles » PMID: 28968414

The Incidence of Induced Abortion in Kinshasa, Democratic Republic of Congo, 2016

Overview
Journal PLoS One
Date 2017 Oct 3
PMID 28968414
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In the Democratic Republic of Congo, the penal code prohibits the provision of abortion. In practice, however, it is widely accepted that the procedure can be performed to save the life of a pregnant woman. Although abortion is highly restricted, anecdotal evidence indicates that women often resort to clandestine abortions, many of which are unsafe. However, to date, there are no official statistics or reliable data to support this assertion.

Objectives: Our study provides the first estimates of the incidence of abortion and unintended pregnancy in Kinshasa.

Methods: We applied the Abortion Incidence Complications Method (AICM) to estimate the incidence of abortion and unintended pregnancy. We used data from a Health Facilities Survey and a Prospective Morbidity Survey to determine the annual number of women treated for abortion complications at health facilities. We also employed data from a Health Professionals Survey to calculate a multiplier representing the number of abortions for every induced abortion complication treated in a health facility.

Results: In 2016, an estimated 37,865 women obtained treatment for induced abortion complications in health facilities in Kinshasa. For every woman treated in a facility, almost four times as many abortions occurred. In total, an estimated 146,713 abortions were performed, yielding an abortion rate of 56 per 1,000 women aged 15-49. Furthermore, more than 343,000 unintended pregnancies occurred, resulting in an unintended pregnancy rate of 147 per 1,000 women aged 15-49.

Conclusions: Increasing contraceptive uptake can reduce the number of women who experience unintended pregnancies, and as a consequence, result in fewer women obtaining unsafe abortions, suffering abortion complications, and dying needlessly from unsafe abortion. Increasing access to safe abortion and improving post-abortion care are other measures that can be implemented to reduce unsafe abortion and/or its negative consequences, including maternal mortality.

Citing Articles

Public hospital-based care for abortive events in Mexico: complication rates and socio-demographic factors, 2018-2022.

Jacobson L, Saavedra-Avendano B, Schiavon R, Darney B BMC Public Health. 2025; 25(1):104.

PMID: 39789473 PMC: 11715974. DOI: 10.1186/s12889-024-21182-5.


Abortion information-seeking experiences among women who obtained abortions in Kinshasa, DRC: Results from a qualitative study.

Ngondo D, Karp C, Kayembe D, Basile K, Moreau C, Akilimali P PLOS Glob Public Health. 2024; 4(2):e0002383.

PMID: 38381761 PMC: 10880974. DOI: 10.1371/journal.pgph.0002383.


Maternal health outcomes in the context of fragility: a retrospective study from Lebanon.

Dimassi H, Alameddine M, Sabra N, El Arnaout N, Harb R, Hamadeh R Confl Health. 2023; 17(1):59.

PMID: 38093261 PMC: 10720064. DOI: 10.1186/s13031-023-00558-1.


Expanding access to safe abortion in DRC: charting the path from decriminalisation to accessible care.

Glover A, Mulunda J, Akilimali P, Kayembe D, Bertrand J Sex Reprod Health Matters. 2023; 31(1):2273893.

PMID: 37955526 PMC: 10653615. DOI: 10.1080/26410397.2023.2273893.


Perils and promise providing information on sexual and reproductive health via the Nurse Nisa WhatsApp chatbot in the Democratic Republic of the Congo.

McMahon E, Fetters T, Jive N, Mpoyi M Sex Reprod Health Matters. 2023; 31(4):2235796.

PMID: 37548472 PMC: 10408565. DOI: 10.1080/26410397.2023.2235796.


References
1.
Elul B, Ellertson C, Winikoff B, Coyaji K . Side effects of mifepristone-misoprostol abortion versus surgical abortion. Data from a trial in China, Cuba, and India. Contraception. 1999; 59(2):107-14. DOI: 10.1016/s0010-7824(99)00003-7. View

2.
Newhall E, Winikoff B . Abortion with mifepristone and misoprostol: regimens, efficacy, acceptability and future directions. Am J Obstet Gynecol. 2000; 183(2 Suppl):S44-53. DOI: 10.1067/mob.2000.107950. View

3.
Borgatta L, Mullally B, Vragovic O, Gittinger E, Chen A . Misoprostol as the primary agent for medical abortion in a low-income urban setting. Contraception. 2004; 70(2):121-6. DOI: 10.1016/j.contraception.2004.03.007. View

4.
Sherris J, Bingham A, Burns M, Girvin S, Westley E, Gomez P . Misoprostol use in developing countries: results from a multicountry study. Int J Gynaecol Obstet. 2004; 88(1):76-81. DOI: 10.1016/j.ijgo.2004.09.006. View

5.
Jewkes R, Rees H . Dramatic decline in abortion mortality due to the Choice on Termination of Pregnancy Act. S Afr Med J. 2005; 95(4):250. View